X

Sandu Pharmaceuticals Ltd Stock Analysis

Small Cap
Evaluated by 123 users | BSE: 524703 | NSE: |
Pharmaceuticals & Drugs
Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.The company is part of Sandu Group of Companies, which was established in the year in 1899. It is also...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 5.86%4.26%5.31%4.55%4.67%5.56%1.58%3.68%3.81%3.14%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 21.631.230.23639.641.142.84949.448.4
Y-o-Y Gr. Rt.-44.7%-3.4%19.1%10.1%3.7%4.3%14.5%0.8%-2.1%
Adjusted EPS (Rs.) 1.180.681.130.70.580.76-0.720.740.951.02
Y-o-Y Gr. Rt.--42.4%66.2%-38.1%-17.1%31%-194.7%NA28.4%7.4%
Book Value per Share (Rs.) 23.2323.9225.0225.7225.6326.3925.0526.227.3928.22
Adjusted Net Profit 0.80.50.80.50.40.5-0.50.50.70.7
Net Op. Cash Flow (Rs. Cr.) 1.20.34.7-1.14.8-1.44.91.23.76.2
Debt to Cash Flow from Ops 2.2811.941.78-9.442.62-7.982.157.641.650.2
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Sandu Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 9.4%4.1%4.1%-2.1%
Adjusted EPS -1.6%12%NA7.4%
Book Value per Share 2.21.94.13
Share Price 8.7% 1.5% -5% 106.6%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 5.212.94.632.762.282.92-2.211.92.362.49
Operating Profit Margin (%) 7.745.876.415.816.156.994.325.034.243.01
Net Profit Margin (%) 3.871.552.661.381.041.31-1.191.081.361.49
Debt to Equity 0.170.230.470.550.690.610.60.510.320.06
Working Capital Days 216178202232245236240184181178
Cash Conversion Cycle 1811481191251128710410110497
Entity Percentage Holding
Promoters 45.04%
Institutions 0.01%
Non-Institutions 54.95%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Sandu Pharmaceuticals Ltd's performance infers:

Sandu Pharmaceuticals Ltd earnings have grown by 12%, whereas share price has appreciated 1.5% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Sandu Pharmaceuticals Ltd share prices over the last 10 years. Here is what we found out:

Sandu Pharmaceuticals Ltd share price has appreciated 8.9% annually over the past ten years.

Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

The company is part of Sandu Group of Companies, which was established in the year in 1899. It is also developing bio-technology and has got encouraging results for the residual, waste products generated after extraction of green herbs, roots, etc.

The company’s state-of-the-art manufacturing unit

Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

The company is part of Sandu Group of Companies, which was established in the year in 1899. It is also developing bio-technology and has got encouraging results for the residual, waste products generated after extraction of green herbs, roots, etc.

The company’s state-of-the-art manufacturing unit is located at Plot No. 25, 26, 29 and 30, Pilerne Industrial Estate, Marra, Bardez, Goa 403511.

Sandu Pharmaceuticals has received ISO 9001-2000 certification for its quality management.

It has also commenced operations of its ‘Sandu Ayurvedic Therapy Centre’, which its plans to establish centres across India via franchisee business model.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback